Eur Rev Med Pharmacol Sci 2021; 25 (9): 3398-3398
DOI: 10.26355/eurrev_202105_25805

LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9

W.-H. Tong, J.-F. Mu, S.-P. Zhang

Department of Gastrointestinal and Colorectal Surgery, The First Hospital of Jilin University, Changchun, China.


The article “LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9, by W.-H. Tong, J.-F. Mu, S.-P. Zhang, published in Eur Rev Med Pharmacol Sci 2020; 24 (12): 6639-6646–DOI: 10.26355/eurrev_202006_21650–PMID: 32633353” has been withdrawn from the authors since they decided to perform further experiments.

The Publisher apologizes for any inconvenience this may cause.

LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9

Free PDF Download

To cite this article

W.-H. Tong, J.-F. Mu, S.-P. Zhang
LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 9
Pages: 3398-3398
DOI: 10.26355/eurrev_202105_25805